In a landmark moment for Scotland’s burgeoning biotech scene, uFraction8, a trailblazing engineering firm based in Falkirk, has clinched a £3.4 million investment to propel its cutting-edge microfiltration technology onto the global stage. The funding round, spearheaded by the visionary Foresight Group, marks a resounding vote of confidence in uFraction8‘s mission to revolutionize bioprocessing with sustainable, scalable solutions. Joining the charge are an impressive roster of backers, including the University of Edinburgh’s Old College Capital, Scottish Enterprise, Alwyn Capital, Thia Ventures, and a pivotal grant from the Polish Agency for Enterprise Development
At the heart of uFraction8‘s innovation lies a microfiltration system designed to transform the production of cell and biomass materials. This technology promises an energy-efficient alternative to conventional methods, unlocking new possibilities in creating food, feed, and bio-based products. With operations spanning Falkirk and a wholly-owned subsidiary in Poznan, Poland, the company is poised to tackle pressing challenges in the global biotech sector, enhancing both affordability and scalability. The fresh capital will fuel the commercialization of this breakthrough, rooted in pioneering research from the University of Edinburgh’s School of Engineering, and amplify its reach across high-impact markets like biopharma—projected to soar to a $30 billion (£24 billion) industry by 2030—and the transformative microalgae sector.
The investment builds on uFraction8‘s momentum, following a £2.5 million round in 2022 led by Thia Ventures. Co-founded by the dynamic duo of Dr. Brian Miller and Dr. Monika Tomecka, the company currently employs a tight-knit team of seven across its Scottish and Polish hubs. Dr. Tomecka, who also serves as CEO, expressed her exhilaration at this milestone: “We’re thrilled to have secured this significant investment, which will drive forward this next stage of our growth. The support from our investors is a testament to the impact and potential of our innovative technology. These funds will ensure we can bring our solutions to market more rapidly, particularly within the microalgae and biopharma sectors, and enable uFraction8 to continue its innovation within the alternative protein sector.”
Rubina Singh, Senior Investment Manager at Foresight Group, echoed this enthusiasm: “We are delighted to be supporting Monika and the uFraction8 team in bringing this breakthrough technology to market. At Foresight Group, we’re committed to supporting pioneering technologies for a sustainable future. uFraction8’s advancements in continuous bioprocessing present transformative opportunities across multiple industries, and we are excited to help the company achieve further impact in their important work.”
Kerry Sharp, Director of Entrepreneurship and Investment at Scottish Enterprise, highlighted the broader implications: “Scottish Enterprise has supported uFraction8’s ambition over several years to develop and commercialize its highly innovative technology, enabling its customers to produce more efficient and scalable bio-based products. The biotech industry is a key opportunity area for growth for Scotland. Companies like uFraction8 can play a vital role in transforming our economy by scaling up, creating high-value jobs, and competing internationally.”
Editorial View: A Beacon of Promise in Biotech’s Bright Future
The trajectory of uFraction8 signals more than just a financial win—it’s a testament to the power of ingenuity meeting opportunity. As the world grapples with sustainability challenges, from food security to pharmaceutical innovation, uFraction8’s focus on energy-efficient bioprocessing positions it as a potential game-changer. Its technology doesn’t just promise incremental improvements; it aims to rewrite the rulebook for industries poised for explosive growth. The microalgae and alternative protein sectors, in particular, stand to benefit from a scalable, cost-effective approach that could democratize access to eco-friendly solutions, making uFraction8 a vital cog in the machinery of a greener tomorrow.
What’s equally compelling is the company’s strategic footing. With roots in Scotland’s rich academic ecosystem and a bridge to Poland’s thriving innovation landscape, uFraction8 embodies a cross-border synergy that amplifies its global potential. The backing of heavyweights like Foresight Group and Scottish Enterprise underscores a broader trend: biotech is no longer a niche pursuit but a cornerstone of economic and environmental progress. By targeting high-growth markets and staying true to its sustainable ethos, uFraction8 is steering in the right direction—toward a future where Scotland shines as a biotech powerhouse.
If you need further assistance or have any corrections, please reach out to editor@thetimesmag.com.
